Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
Provided By GlobeNewswire
Last update: Mar 13, 2025
SAN DIEGO and SUZHOU, China, March 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its presentation at the 11th Annual Immuno-Oncology 360⁰ Summit in Boston on March 26, 2025.
Read more at globenewswire.com
